Doctor profile · Federal record
Dr. Samir Desai, MD
Hematology & Oncology Physician (CMS: Hematology/Oncology) · Hematology & Oncology Physician · Plainfield, IL
- NPI 1659372506
- Accepts Medicare
- 21 yrs in practice
- Licensed in 2 states
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
12004 S Route 59 Unit 100
Plainfield, IL 605855108
(630) 364-7850 - Mailing address
-
Po Box 713260
Chicago, IL 606771260
Credentials & registration
- NPI registered
- August 2005 — 21 yrs on file
- Profile last updated
- August 4, 2023
- Year of graduation
- 2005 — 21 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State licenses (2)
- Illinois #036147500 · Oregon #MD25984
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1659372506. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
78,979
Distinct HCPCS
10
Medicare allowed
$883,376
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J1453 |
Injection, fosaprepitant, 1 mg | 18,300 | 46 | $0 | |
Q0138 |
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 15,810 | 21 | $0 | |
J0897 |
Injection, denosumab, 1 mg | 9,240 | 25 | $22 | |
J9267 |
Injection, paclitaxel, 1 mg | 8,598 | 16 | $0 | |
J1756 |
Injection, iron sucrose, 1 mg | 7,000 | 15 | $0 | |
J0129 |
Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 6,150 | 24 | $42 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 2,048 | 53 | $0 | |
Q5119 |
Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg | 1,780 | 14 | $27 | |
J2469 |
Injection, palonosetron hcl, 25 mcg | 1,230 | 47 | $1 | |
J1745 |
Injection, infliximab, excludes biosimilar, 10 mg | 1,190 | 13 | $33 |
In context: peer comparison
Among 1 peers in Plainfield Hematology & Oncology Physician, average services per provider: 1,128. This provider delivers 70× the peer median.Open Payments
Industry payments received
All-time total
$4,511
Transactions
34
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Daiichi Sankyo INC. | 5 | $1,781.18 | |
| Pfizer INC. | 7 | $1,310.95 | |
| Avyxa Pharma, LLC | 1 | $423.53 | |
| Pharmacosmos Therapeutics INC. | 3 | $181.08 | |
| US Oncology Corporate, INC. | 1 | $121.77 | |
| Lilly USA, LLC | 1 | $108.62 | |
| Novartis Pharmaceuticals Corporation | 3 | $71.15 | |
| Merck Sharp & Dohme LLC | 3 | $63.00 | |
| Abbvie INC. | 2 | $52.35 | |
| E.R. Squibb & Sons, L.L.C. | 2 | $45.57 | |
| Takeda Pharmaceuticals U.S.A., INC. | 1 | $43.35 | |
| Celgene Corporation | 2 | $41.84 | |
| Jazz Pharmaceuticals INC. | 1 | $39.11 | |
| Incyte Corporation | 1 | $27.50 | |
| Emd Serono, INC. | 1 | $26.72 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
137
Patients
38
Total drug cost
$52,229
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Anastrozole | Generic | 47 | 16 | $1,103 |
| Eliquis (Apixaban) | Brand | 25 | 11 | $29,558 |
| Prednisone | Generic | 20 | 11 | $128 |
| Xarelto (Rivaroxaban) | Brand | 17 | 0 | $20,825 |
| Warfarin Sodium | Generic | 16 | 0 | $153 |
| Letrozole | Generic | 12 | 0 | $462 |
Frequently asked questions
What is Dr. Samir Desai's medical specialty?
Dr. Samir Desai practices Hematology & Oncology Physician in Plainfield, IL.
Where does Dr. Samir Desai practice?
Dr. Samir Desai practices at 12004 S Route 59 Unit 100, Plainfield, IL 605855108. Office phone: 6303647850.
What is Dr. Samir Desai's NPI?
Dr. Samir Desai's National Provider Identifier (NPI) is 1659372506, issued by NPPES.
Does Dr. Samir Desai accept Medicare assignment?
Yes. Dr. Samir Desai accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Samir Desai commonly perform?
Top Medicare-reported procedures in 2023: Injection, fosaprepitant, 1 mg (HCPCS J1453); Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS Q0138); Injection, denosumab, 1 mg (HCPCS J0897). Source: CMS Medicare Physician & Other Practitioners file.